Understanding Cystic Fibrosis and its Effects
Diagnosis and Treatment of Patients With Cystic Fibrosis
National Institutes of Health Clinical Center (CC) · NCT00001223
This study looks at people with cystic fibrosis to gather information during their regular check-ups to help understand how the disease affects them over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 9999 (estimated) |
| Ages | 4 Years to 120 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) (nih) |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT00001223 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with cystic fibrosis to gather samples and data during standard clinical care. The goal is to enhance knowledge about the natural history, clinical manifestations, and genetic variants associated with cystic fibrosis. By collecting this information, researchers aim to better understand the disease and its impact on patients over time.
Who should consider this trial
Good fit: Ideal candidates include patients with known or suspected cystic fibrosis and their family members, aged 4 years and older.
Not a fit: Patients with significant concomitant medical or psychiatric issues that complicate the interpretation of cystic fibrosis studies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of cystic fibrosis, ultimately enhancing patient care.
How similar studies have performed: Other studies focusing on the natural history and genetic aspects of cystic fibrosis have shown promise, indicating that this approach is supported by previous research.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA * Patients with known or suspected CF and family members of patients with CF. * \>=4 years of age EXCLUSION CRITERIA -Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (RECRUITING)
Study contacts
- Principal investigator: Milica S Chernick, M.D. — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study coordinator: Milica S Chernick, M.D.
- Email: milicac@bdg10.niddk.nih.gov
- Phone: (301) 496-3434
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cystic Fibrosis, Liver Disease or Abnormalities, Diabetes, Pancreatic Insufficiency, Bronchiectasis, Liver Disease, Natural History